메뉴 건너뛰기




Volumn 16, Issue 10, 2014, Pages 1049-1055

The middle child in heart failure: Heart failure with mid-range ejection fraction (40-50%)

Author keywords

Ejection fraction; heart failure

Indexed keywords

CREATININE; HEMOGLOBIN; NATRIURETIC PEPTIDE RECEPTOR B; UREA; CARDIOVASCULAR AGENT;

EID: 84907976840     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.159     Document Type: Review
Times cited : (175)

References (23)
  • 4
    • 84899510381 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: A clinical dilemma
    • Komajda M, Lam CS,. Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J. 2014; 35: 1022-1032.
    • (2014) Eur Heart J. , vol.35 , pp. 1022-1032
    • Komajda, M.1    Lam, C.S.2
  • 5
    • 84892991005 scopus 로고    scopus 로고
    • HFNEF, HFPEF, HF-PEF, or DHF: What is in an acronym?
    • Sanderson JE,. HFNEF, HFPEF, HF-PEF, or DHF: what is in an acronym? JACC Heart Fail 2014; 2: 93-94.
    • (2014) JACC Heart Fail , vol.2 , pp. 93-94
    • Sanderson, J.E.1
  • 10
    • 84867745957 scopus 로고    scopus 로고
    • Prospective comparison of ARNI with ARB on Management of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial
    • Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ,. Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet 2012; 380: 1387-1395.
    • (2012) Lancet , vol.380 , pp. 1387-1395
    • Solomon, S.D.1    Zile, M.2    Pieske, B.3    Voors, A.4    Shah, A.5    Kraigher-Krainer, E.6    Shi, V.7    Bransford, T.8    Takeuchi, M.9    Gong, J.10    Lefkowitz, M.11    Packer, M.12    McMurray, J.J.13
  • 13
    • 34547837711 scopus 로고    scopus 로고
    • Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF registry
    • OPTIMIZE-HF Investigators and Hospitals
    • Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 2007; 50: 768-777.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 768-777
    • Fonarow, G.C.1    Stough, W.G.2    Abraham, W.T.3    Albert, N.M.4    Gheorghiade, M.5    Greenberg, B.H.6    O'Connor, C.M.7    Sun, J.L.8    Yancy, C.W.9    Young, J.B.10
  • 14
    • 79955759374 scopus 로고    scopus 로고
    • Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum
    • discussion 2014
    • Borlaug BA, Redfield MM,. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 2011; 123: 2006-2013; discussion 2014.
    • (2011) Circulation , vol.123 , pp. 2006-2013
    • Borlaug, B.A.1    Redfield, M.M.2
  • 15
    • 84903154515 scopus 로고    scopus 로고
    • Implications of coronary artery disease in heart failure with preserved ejection fraction
    • Hwang SJ, Melenovsky V, Borlaug BA,. Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014; 63: 2817-2827.
    • (2014) J Am Coll Cardiol. , vol.63 , pp. 2817-2827
    • Hwang, S.J.1    Melenovsky, V.2    Borlaug, B.A.3
  • 16
    • 61349151722 scopus 로고    scopus 로고
    • Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%
    • He KL, Burkhoff D, Leng WX, Liang ZR, Fan L, Wang J, Maurer MS,. Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. Am J Cardiol 2009; 103: 845-851.
    • (2009) Am J Cardiol , vol.103 , pp. 845-851
    • He, K.L.1    Burkhoff, D.2    Leng, W.X.3    Liang, Z.R.4    Fan, L.5    Wang, J.6    Maurer, M.S.7
  • 18
    • 0041356972 scopus 로고    scopus 로고
    • Natural history of asymptomatic left ventricular systolic dysfunction in the community
    • Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS,. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108: 977-982.
    • (2003) Circulation , vol.108 , pp. 977-982
    • Wang, T.J.1    Evans, J.C.2    Benjamin, E.J.3    Levy, D.4    Leroy, E.C.5    Vasan, R.S.6
  • 20
    • 34548154261 scopus 로고    scopus 로고
    • Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)
    • Midlands Research Practices Consortium (MidReC)
    • Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R, Midlands Research Practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J 2007; 28: 1128-1134.
    • (2007) Eur Heart J , vol.28 , pp. 1128-1134
    • Hobbs, F.D.1    Roalfe, A.K.2    Davis, R.C.3    Davies, M.K.4    Hare, R.5
  • 21
    • 84880118241 scopus 로고    scopus 로고
    • The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-analysis
    • Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
    • Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33: 1750-1757.
    • (2012) Eur Heart J , vol.33 , pp. 1750-1757
  • 22
    • 0041408234 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
    • CHARM Investigators and Committees
    • Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781.
    • (2003) Lancet , vol.362 , pp. 777-781
    • Yusuf, S.1    Pfeffer, M.A.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    McMurray, J.J.6    Michelson, E.L.7    Olofsson, B.8    Ostergren, J.9
  • 23
    • 84875442830 scopus 로고    scopus 로고
    • The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)
    • Kutyifa V, Kloppe A, Zareba W, Solomon SD, McNitt S, Polonsky S, Barsheshet A, Merkely B, Lemke B, Nagy VK, Moss AJ, Goldenberg I,. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2013; 61: 936-944.
    • (2013) J Am Coll Cardiol , vol.61 , pp. 936-944
    • Kutyifa, V.1    Kloppe, A.2    Zareba, W.3    Solomon, S.D.4    McNitt, S.5    Polonsky, S.6    Barsheshet, A.7    Merkely, B.8    Lemke, B.9    Nagy, V.K.10    Moss, A.J.11    Goldenberg, I.12


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.